- Home
- KRKR vs BFRI Comparison
KRKR vs BFRI Comparison
Compare KRKR & BFRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRKR
- BFRI
- Stock Information
- Founded
- KRKR 2010
- BFRI 1997
- Country
- KRKR China
- BFRI United States
- Employees
- KRKR N/A
- BFRI N/A
- Industry
- KRKR Business Services
- BFRI Biotechnology: Pharmaceutical Preparations
- Sector
- KRKR Consumer Discretionary
- BFRI Health Care
- Exchange
- KRKR Nasdaq
- BFRI Nasdaq
- Market Cap
- KRKR 9.1M
- BFRI 8.7M
- IPO Year
- KRKR 2019
- BFRI 2021
- Fundamental
- Price
- KRKR $4.02
- BFRI $0.78
- Analyst Decision
- KRKR
- BFRI Strong Buy
- Analyst Count
- KRKR 0
- BFRI 1
- Target Price
- KRKR N/A
- BFRI $7.00
- AVG Volume (30 Days)
- KRKR 19.8K
- BFRI 90.9K
- Earning Date
- KRKR 03-11-2025
- BFRI 03-21-2025
- Dividend Yield
- KRKR N/A
- BFRI N/A
- EPS Growth
- KRKR N/A
- BFRI N/A
- EPS
- KRKR N/A
- BFRI N/A
- Revenue
- KRKR $31,657,328.00
- BFRI $37,321,000.00
- Revenue This Year
- KRKR $182.55
- BFRI $28.62
- Revenue Next Year
- KRKR N/A
- BFRI $27.07
- P/E Ratio
- KRKR N/A
- BFRI N/A
- Revenue Growth
- KRKR N/A
- BFRI 9.54
- 52 Week Low
- KRKR $2.76
- BFRI $0.65
- 52 Week High
- KRKR $12.99
- BFRI $2.43
- Technical
- Relative Strength Index (RSI)
- KRKR 48.56
- BFRI 33.18
- Support Level
- KRKR $3.93
- BFRI $0.77
- Resistance Level
- KRKR $4.26
- BFRI $0.96
- Average True Range (ATR)
- KRKR 0.21
- BFRI 0.08
- MACD
- KRKR 0.03
- BFRI -0.01
- Stochastic Oscillator
- KRKR 40.35
- BFRI 2.70
About KRKR 36Kr Holdings Inc.
36KR Holdings Inc is a holding company and conducts its business mainly through its subsidiaries, a VIE, and subsidiaries of the VIE. The Group is engaging in providing content and business services to new economy participants in the PRC. Its content production process includes content creation, content editing, screening and monitoring, and content distribution. The Group mainly generates revenues from providing online advertising services, enterprise value-added services, and subscription services. The Group's principal operations and geographic markets are substantially located in PRC.
About BFRI Biofrontera Inc.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy (PDT) and topical antibiotics. Its licensed products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. Its licensed product is Ameluz, which is a prescription drug approved for use in combination with the RhodoLED lamp series, for PDT (when used together, Ameluz PDT). including the complementary product BF-RhodoLED, and Xepi.